Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives

Nanotechnology has been actively integrated as drug carriers over the last few years to treat various cancers. The main hurdle in the clinical management of cancer is the development of multidrug resistance against chemotherapeutic agents. To overcome the limitations of chemotherapy, the researchers...

Descripción completa

Detalles Bibliográficos
Autores principales: Edis, Zehra, Wang, Junli, Waqas, Muhammad Khurram, Ijaz, Muhammad, Ijaz, Munazza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898224/
https://www.ncbi.nlm.nih.gov/pubmed/33628022
http://dx.doi.org/10.2147/IJN.S289443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898224/
https://www.ncbi.nlm.nih.gov/pubmed/33628022
http://dx.doi.org/10.2147/IJN.S289443

Ejemplares similares